Support for a center focused on prostate cancer biomarker research
Official title: Admin Core
Funded at Johns Hopkins University · NIH-10890723 · Data updated 2026-11-12
This study is all about improving how we work together to find new ways to detect prostate cancer early, which can help patients get better care and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 20, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $354,330 |
| NIH project number | 5U2CCA271895-02 |
| Project ID | NIH-10890723 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for prostate cancer or those undergoing evaluation for prostate-related conditions.
✕Less likely to help
Patients who are not at risk for prostate cancer or those with advanced, untreatable stages of the disease may not benefit from this research.
What this research studies
This research aims to provide essential logistical and managerial support for a Biomarker Characterization Center dedicated to prostate cancer. It will enhance collaboration among various research teams and centers, ensuring effective communication and coordination. The project will focus on validating biomarkers that can aid in the early detection of prostate cancer, ultimately improving patient outcomes. By fostering teamwork and sharing insights, the center aims to align with national cancer research goals and enhance the overall success of the Early Detection Research Network.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for early detection of prostate cancer, potentially saving lives through timely intervention.
How similar studies have gone: Previous research has shown success in similar collaborative approaches to biomarker validation, indicating a promising potential for this initiative.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Chan, Daniel Wanyui — Johns Hopkins University
- Study coordinator: Chan, Daniel Wanyui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.